RedHill Biopharma (RDHL) Common Equity (2011 - 2025)
RedHill Biopharma (RDHL) posted quarterly Common Equity of $4.3 million for Q4 2025, up 191.14% year-over-year from $1.5 million in Q4 2024, and up 196.74% quarter-over-quarter from -$4.4 million in Q2 2025.
RedHill Biopharma (RDHL) Common Equity (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Common Equity for 15 consecutive years, with $4.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Common Equity rose 191.14% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $4.3 million (up 191.14% YoY), while the FY2025 annual figure was $4.3 million, up 191.14% from the prior year.
- Common Equity rose to $4.3 million in Q4 2025 per RDHL's latest filing, from -$4.4 million in the prior quarter.
- Across five years, Common Equity topped out at $53.0 million in Q1 2021 and bottomed at -$48.4 million in Q4 2022.
- Historically, Common Equity has averaged -$798642.9 across 5 years, with a median of $1.1 million in 2023.
- On a YoY basis, Common Equity climbed as much as 191.14% in 2025 and fell as far as 7332.79% in 2025.
- RedHill Biopharma's Common Equity stood at $8.9 million in 2021, then sank by 645.35% to -$48.4 million in 2022, then surged by 104.27% to $2.1 million in 2023, then slumped by 326.34% to -$4.7 million in 2024, then surged by 191.14% to $4.3 million in 2025.
- Business Quant data shows RDHL's Common Equity at $4.3 million in Q4 2025, -$4.4 million in Q2 2025, and -$4.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | 4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.27 Mn |
| Jun 30, 2025 | -4.41 Mn |
| Dec 31, 2024 | -4.68 Mn |
| Jun 30, 2024 | 61,000.00 |
| Dec 31, 2023 | 2.07 Mn |
| Jun 30, 2023 | 3.47 Mn |
| Dec 31, 2022 | -48.40 Mn |
| Sep 30, 2022 | -46.03 Mn |
| Jun 30, 2022 | -11.94 Mn |
| Mar 31, 2022 | -8.63 Mn |
| Dec 31, 2021 | 8.88 Mn |
| Sep 30, 2021 | 11.55 Mn |
| Jun 30, 2021 | 29.58 Mn |
| Mar 31, 2021 | 53.04 Mn |
| Dec 31, 2020 | 13.86 Mn |
| Sep 30, 2020 | 28.75 Mn |
| Jun 30, 2020 | 34.59 Mn |
| Mar 31, 2020 | 43.65 Mn |
| Dec 31, 2019 | 60.00 Mn |
| Sep 30, 2019 | 22.85 Mn |